Philanthropic giving by foundations has been and continues to be an important contribution to social, economic and environmental justice here and abroad. Yet, foundations are unnecessarily limiting themselves.
Patient capital is vital for early-stage investing when the company must confront significant challenges to disrupt an industry. At this stage, few other than philanthropy-based patient capital will take the financial risk the company needs for experimentation.
A true entrepreneur, Jens founded his first company at age 18. He is CEO of JRX Ghana, a company which specializes in connecting non-African companies with African firms to create win-win business for all.
When we handed Eric the money he earned, his face broke into smiles. "This is so amazing! I've never seen so much cash in one place in my life." Eric continued to grasp the roll of money in both hands, as if feeling its heft over and over.
We must ensure that, here at home, the urgency of the moment bolsters a unified vision and continuous legacy of policy innovation, creating pathways of opportunity for low-income people and places and making the American dream an achievable reality.
The care is delivered to the patient and their family or support system, usually by a team of experts that include physicians, nurses, social workers, health aides, chaplains as well as support personnel."
The recent release of details about the performance of several impact investment portfolios and funds is another step toward answering the question more and more investors are asking: Is impact a boost -- or a bust -- in terms of financial returns?
By the time I launched my mutual funds the motivation for socially responsible investing had moved from 'consistent with my own values' to 'consistent with the values of human dignity and ecological sustainability.'